Dentsply Sirona (XRAY) Current Deferred Revenue (2009 - 2021)
Dentsply Sirona (XRAY) posted Current Deferred Revenue of $68.0 million for Q4 2021, up 28.3% on a QoQ basis from $53.0 million in Q4 2020, and up 28.3% year-over-year from $53.0 million in Q4 2020.
Dentsply Sirona (XRAY) Current Deferred Revenue (2009 - 2021) Analysis & Trends
Dentsply Sirona's Current Deferred Revenue history runs 4 years deep, the most recent figure standing at $68.0 million for Q4 2021.
- Quarterly Current Deferred Revenue rose 28.3% year-over-year to $68.0 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $68.0 million (up 28.3% YoY) and the FY2021 annual result came in at $68.0 million, up 28.3% from the prior year.
- Current Deferred Revenue was $68.0 million for Q4 2021 at Dentsply Sirona, up from $53.0 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $68.0 million in Q4 2021 and bottomed at $53.0 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Dentsply Sirona | 2.54 Bn | 2.35 Bn | 427.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 68.00 Mn |
| Dec 31, 2020 | 53.00 Mn |
| Dec 31, 2010 | 5.66 Mn |
| Dec 31, 2009 | 3.39 Mn |